| Literature DB >> 33198367 |
Toly Chen1, Yu-Cheng Wang2, Min-Chi Chiu3.
Abstract
The COVID-19 pandemic has affected the operations of factories worldwide. However, the impact of the COVID-19 pandemic on different factories is not the same. In other words, the robustness of factories to the COVID-19 pandemic varies. To explore this topic, this study proposes a fuzzy collaborative intelligence approach to assess the robustness of a factory to the COVID-19 pandemic. In the proposed methodology, first, a number of experts apply a fuzzy collaborative intelligence approach to jointly evaluate the relative priorities of factors that affect the robustness of a factory to the COVID-19 pandemic. Subsequently, based on the evaluated relative priorities, a fuzzy weighted average method is applied to assess the robustness of a factory to the COVID-19 pandemic. The assessment result can be compared with that of another factory using a fuzzy technique for order preference by similarity to ideal solution. The proposed methodology has been applied to assess the robustness of a wafer fabrication factory in Taiwan to the COVID-19 pandemic.Entities:
Keywords: COVID-19 pandemic; fuzzy collaborative intelligence; robustness; wafer fabrication
Year: 2020 PMID: 33198367 PMCID: PMC7712638 DOI: 10.3390/healthcare8040481
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Factors affecting the robustness of a factory to the COVID-19 pandemic.
Actions taken by supply chain participants in the short and long terms.
| Term | Actions |
|---|---|
| Short term |
Move raw material inventory to places free from quarantine and easy to ship [ Secure the capacity and delivery plan of upstream raw material suppliers and downstream assembly factories [ Procure materials that may be in short supply in advance [ Secure future transportation services [ Find or activate alternative suppliers [ Negotiate with customers on possible delays or cancellation [ |
| Long term |
Modify product designs to accept alternative raw materials [ Establish formal cooperative relations with suppliers outside impacted regions [ Assess the operational and financial risk and impact of the COVID-19 pandemic [ Modify long-term supply plan and demand forecasts [ Develop factory response/closure plan [ |
Figure 2Four types of factory shutdowns amid the COVID-19 pandemic (red parts indicating the causes of shutdowns).
Figure 3The main parts of the proposed methodology.
Figure 4The fuzzy intersection result of five experts’ judgments without a consensus.
Figure 5The partial consensus among any four experts in the previous example.
Figure 6The partial consensus among any three experts in the previous example.
Figure 7Approximating the PCFI result with a TFN.
Figure 8The convergence process of the ranking result.
Results of pairwise comparisons.
|
| ||
|
|
|
|
| Pandemic severity | Pandemic containment performance | Weakly more important than |
| Vaccine acquisition speed | Pandemic containment performance | Weakly or strongly more important than |
| Pandemic containment performance | Demand shrinkage | Strongly more important than |
| Pandemic containment performance | Supplier impact | Strongly more important than |
| Pandemic containment performance | Infection risk | Strongly more important than |
| Vaccine acquisition speed | Pandemic severity | Strongly more important than |
| Demand shrinkage | Pandemic severity | Weakly more important than |
| Pandemic severity | Supplier impact | Weakly or strongly more important than |
| Pandemic severity | Infection risk | As equal as or weakly more important than |
| Vaccine acquisition speed | Demand shrinkage | Weakly more important than |
| Vaccine acquisition speed | Supplier impact | Strongly more important than |
| Vaccine acquisition speed | Infection risk | Strongly more important than |
| Demand shrinkage | Supplier impact | Strongly more important than |
| Demand shrinkage | Infection risk | Strongly more important than |
| Supplier impact | Infection risk | Weakly more important than |
|
| ||
|
|
|
|
| Pandemic containment performance | Pandemic severity | Weakly more important than |
| Vaccine acquisition speed | Pandemic containment performance | Strongly more important than |
| Demand shrinkage | Pandemic containment performance | Strongly more important than |
| Pandemic containment performance | Supplier impact | Weakly or strongly more important than |
| Infection risk | Pandemic containment performance | Weakly more important than |
| Vaccine acquisition speed | Pandemic severity | Strongly more important than |
| Demand shrinkage | Pandemic severity | Strongly more important than |
| Supplier impact | Pandemic severity | Weakly more important than |
| Pandemic severity | Infection risk | As equal as or weakly more important than |
| Demand shrinkage | Vaccine acquisition speed | Weakly more important than |
| Vaccine acquisition speed | Supplier impact | Weakly more important than |
| Vaccine acquisition speed | Infection risk | Strongly more important than |
| Demand shrinkage | Supplier impact | Strongly or very strongly more important than |
| Demand shrinkage | Infection risk | Strongly more important than |
| Supplier impact | Infection risk | Weakly more important than |
|
| ||
|
|
|
|
| Pandemic severity | Pandemic containment performance | Weakly more important than |
| Vaccine acquisition speed | Pandemic containment performance | Weakly more important than |
| Demand shrinkage | Pandemic containment performance | Strongly more important than |
| Supplier impact | Pandemic containment performance | As equal as or weakly more important than |
| Pandemic containment performance | Infection risk | Weakly more important than |
| Vaccine acquisition speed | Pandemic severity | Weakly or strongly more important than |
| Demand shrinkage | Pandemic severity | Weakly more important than |
| Supplier impact | Pandemic severity | Strongly more important than |
| Infection risk | Pandemic severity | Weakly more important than |
| Demand shrinkage | Vaccine acquisition speed | As equal as or weakly more important than |
| Vaccine acquisition speed | Supplier impact | Weakly more important than |
| Vaccine acquisition speed | Infection risk | Strongly or very strongly more important than |
| Demand shrinkage | Supplier impact | Weakly or strongly more important than |
| Demand shrinkage | Infection risk | Strongly more important than |
| Supplier impact | Infection risk | Weakly more important than |
Figure 9The relative priorities of factors evaluated by experts.
Figure 10The FI result of the relative priorities evaluated by experts.
Figure 11The 2/3 PCFI result.
Approximating TFNs.
|
|
|
|---|---|
| 1 | (0.090, 0.144, 0.210) |
| 2 | (0.060, 0.105, 0.150) |
| 3 | (0.210, 0.345, 0.480) |
| 4 | (0.230, 0.291, 0.350) |
| 5 | (0.070, 0.096, 0.120) |
| 6 | (0.030, 0.065, 0.110) |
Rules for evaluating the performances.
| Factor | Rule |
|---|---|
| Pandemic containment performance | |
| Pandemic severity | |
| Vaccine acquiring speed | |
| Demand shrinkage | |
| Supplier impact | |
| Infection risk |
Data of the wafer fab in the six aspects.
| Factor | Data (Collected on October 2) |
|---|---|
| Pandemic containment performance |
The recovery index of the region was 77.99 [ The maximum and minimum of the recovery index were 87.24 (Australia) and 9.38 (Honduras). |
| Pandemic severity |
The current number of active cases in the region was 24 [ The maximum and minimum of the current number of active cases were 2,545,390 (USA) and 1 (Mongolia and four other countries). |
| Vaccine acquisition speed |
Three locally developed COVID-19 vaccines were in phase 1. |
| Demand shrinkage |
The demand for major products, integrated circuits for wireless networks and panel drivers, did not shrink significantly. |
| Supplier impact |
Supplier were located in Taiwan (very lowly impacted), Netherlands (highly impacted), and USA (very highly impacted). |
| Infection risk |
Travelling abroad for business and personal trips has been suspended and discouraged. All types of wafer fabrication equipment are operated in a clean room. Employees wear clean room suits at all times. The probability of infection within the wafer fab is small. Most types of wafer fabrication equipment are highly automated. Employees work independently. There is little chance of contact with each other. |
Evaluation results.
|
|
|
|---|---|
| 1 | (3, 4, 5) |
| 2 | (4, 5, 5) |
| 3 | (0, 1, 2) |
| 4 | (3, 4, 5) |
| 5 | (3, 4, 5) |
| 6 | (3, 4, 5) |
Robustness of the wafer fab after improving the performance in optimizing each factor.
|
|
|
|---|---|
| 1 | 3.503 |
| 2 | 3.471 |
| 3 | 3.506 |
| 4 | 3.541 |
| 5 | 3.493 |
| 6 | 3.484 |